5口服免疫和口服疫苗课件.ppt

上传人(卖家):晟晟文业 文档编号:4568725 上传时间:2022-12-20 格式:PPT 页数:76 大小:1.53MB
下载 相关 举报
5口服免疫和口服疫苗课件.ppt_第1页
第1页 / 共76页
5口服免疫和口服疫苗课件.ppt_第2页
第2页 / 共76页
5口服免疫和口服疫苗课件.ppt_第3页
第3页 / 共76页
5口服免疫和口服疫苗课件.ppt_第4页
第4页 / 共76页
5口服免疫和口服疫苗课件.ppt_第5页
第5页 / 共76页
点击查看更多>>
资源描述

1、Oral Tolerance State of immunological unresponsiveness to antigen induced by feeding.It is a feature of the common mucosal immune system.The mucosal immune system Consists of the gastro-intestinal tract,respiratory system,genito-urinary system,liver.Common lymphoid circulation Epithelial cells line

2、the mucosa Largest area exposed to the external environment Heaviest antigenic loadFeatures of mucosal tolerance?Normal immune function Tolerance can be local or systemic It requires a functional immune system Symbiosis-in the absence of commensals,a poor immune response develops and oral tolerance

3、cannot be inducedGeneral properties of mucosal tolerance:Antigen specific.Often partial(eg.antibodies inhibited,but T cell responses may remain).Not complete(eg.may be a quantitative reduction in antibody levels).Wanes with time.General properties of mucosal tolerance contd Easier to abrogate a resp

4、onse than reduce and established response.Good immunogens are better at inducing tolerance!(adjuvant)Dose and route dependent.Breakdown of oral tolerance Immune responses to food leads to food intolerance eg coeliac disease Immune responses to commensal bacteria leads to inflammatory bowel disease(I

5、BD)eg crohns disease,ulcerative colitisBalanceRespond Dont respondfight and eradicateIgnorePATHOGENS SELFFOODMechanism?Central tolerance deletion of self-reactive T cells in the thymus Peripheral tolerance an area of very active research!1.deletion 2.immune deviation 3.anergy 4.suppression/regulatio

6、nRegulation of self tolerance?Central tolerance is incomplete TCR bind at low affinity and can potentially recognise a number of MHC/peptide Auto-reactive T cells exist at high frequency in the periphery Auto-immunity-is it a result of defective T cell regulation?1.Deletion Mechanism of central tole

7、rance(negative selection in the thymus)Apoptosis of specific T lymphocytes(eg fas-fasL)Shown to play a role in peripheral tolerance in sites of immune privilege(eg stromal cells in the testes express fasL)Peripheral deletion of antigen-reactive T cells in oral toleranceREF:Nature 1995 Jul 13;376(653

8、6):177-80 Chen Y,Inobe J,Marks R,Gonnella P,Kuchroo VK,Weiner HL oral antigen can delete antigen-reactive T cells in Peyers patches,in mice transgenic for the ovalbumin-specific T-cell receptor genes.The deletion was mediated by apoptosis,and was dependent on dosage and frequency of feeding.At lower

9、 doses deletion was not observed;instead there was induction of antigen-specific cells that produced transforming growth factor(TGF)-beta and interleukin(IL)-4 and IL-10 cytokines.At higher doses,both Th1 and Th2 cells were deleted following their initial activation,whereas cells which secrete TGF-b

10、eta were resistant to deletion.These findings demonstrate that orally administered antigen can induce tolerance not only by active suppression and clonal anergy but by extrathymic deletion of antigen-reactive Th1 and Th2 cellsDeletion summary Generally observed at high doses of fed antigen:Activatio

11、n induced cell death(AICD)mediated by fas/fasL interactionsGrowth factor deprival2.Immune Deviation CD4+T lymphocytes are activated by antigen presenting cells(APC)Th1 cells-important in inflammatory responses(eg delayed type hypersensitivity)Th2 cells-important in helping antibody responses.Suppres

12、s Th1 cells(IL-4,IL-10).Therefore Th1 immune responses may be inhibited if Th2 cells are stimulated instead.Inhibitory cytokines Transforming growth factor beta(TGF)non-specifically inhibits the growth of lymphocytes(Th3)Specific immune responses can be inhibited by Th2 cytokines(IL-4 and IL-10)Some

13、 populations of T lymphocytes(both CD4 and CD8)can consume IL-2,the T cell growth factor.Surrounding cells therefore fail to growOne example of many Feeding oral insulin to mice prevents virus induced insulin-dependent diabetes in a mouse model.IL-4 and IL-10 were generated which inhibited a specifi

14、c immune response.REF:Von Herrath et al.,J Clin Invest 98,1324.1996Bystander suppression Antigen-specific suppression is induced by feeding Suppression is triggered by re-encounter of antigen Release of inhibitory cytokines will non-specifically inhibit other cells3.Anergy Non-productive antigen pre

15、sentation T cells are activated by antigen presenting cells3 signals are required to activate a T cellSpecific recognition-TCR sees the right MHC-peptide complex.signal 1Costimulation-CD28 binds B7 signal 2Cytokines-local micro-environment will instruct the kind of T cell needed signal 3Response vs

16、non-response T lymphocyte activation requires 2 signalsSignal T cell proliferation+Signal (IL-2&IL-2r)Signal alone No proliferationSignal 2 absence/blockade Some epithelial cells in the gut and lung normally express class II MHC,but not costimulatory molecules and therefore cannot provide signal 2 R

17、eagents(eg CTLA4 Ig)have been developed to block the interaction of CD28 with B7 on APC and therefore block signal 2Anergy Results in a specific hypresponsiveness Anergic cells do not respond to specific MHC+peptide plus costimulation Anergic cells may then block APC-and inhibit immune responses Ane

18、rgic cells may consume IL-2 Anergic cells are more susceptible to programmed cell death(apoptosis)Ref-Cobbold S&Waldmann H(1998)Infectious Tolerance.Current Opinion inImmunology 10,518-5243.Regulation There has been a great deal of discussion of suppressor cells(especially in the 1980s)Suppressor ce

19、lls have proved difficult to clone and phenotype Many cells exert a suppressive effect A range of regulatory T cells(Treg)have now been describedRegulatory T cells A population of CD4+T cells has been implicated in the suppression of inflammatory immune responses Antigen specific Turn off specific i

20、nflammatory immune responses Mechanism unclearT reg in murine inflammatory bowel disease Pathogenic T cells(Tpath)-can transfer the disease to nave recipients Regulatory T cells(Treg)-inhibit disease&Tpath Treg are a subset of helper T cells(CD4)which express CD25 Major area of investigation in Immu

21、nology ResearchModels of oral tolerance Eat soluble antigen Inject antigen Measure immune response T cell proliferation antibody production cytokine profileMultiple models of oral tolerance have been proposed(Weiner,1997)Animal models Human models Clinical trialsA murine model-Garside Murine model i

22、n which OVA-specific T cells could be tracked with a specific monoclonal antibody Fed OVA Watch immune response by tracking OVA-specific T cellsSmith KM,McAskill F,Garside P.Orally tolerized T cells are only able to enter B cell follicles following challenge with antigen in adjuvant,but they remain

23、unable to provide B cell help.J Immunol 2002 May 1;168(9):4318-25Results PRIMING-Ova injection resulted in:specific antibody production proliferation of OVA specific T cells DTH response TOLERANCE-Feeding Ova abrogated these responses demonstrated that priming and tolerance could be induced in this

24、model.Where did the responses take place?PRIMING d3 peak of OVA specific T cells in peripheral lymph nodeTOLERANCE d3 peak of OVA specific T cells in peripheral lymph nodeT cell proliferationPRIMING T cell division in peripheral lymph nodes(pln),mesenteric lymph nodes(mln)and peyers patches(pp)at 2

25、daysTOLERANCE T cell division in peripheral lymph nodes(pln),mesenteric lymph nodes(mln)and peyers patches(pp)at 2 daysT cell phenotypePRIMING Ova specific T cells develop a memory phenotype.Changes detected as early as 6h after feeding.TOLERANCE Ova specific T cells develop a memory phenotype.Chang

26、es detected as early as 6h after feeding.Differences.Early systemic and local immune response in priming and tolerance was very similar However,later immune responses were very different(immunity vs tolerance)Tolerant T cells did not move into B cell area and stimulate their expansionPotential Can o

27、ral tolerance be used therapeutically?Do inbred animal models relate to outbred human populations?Can mechanisms of regulation be generated ex vivo or in vivo for clinical treatment?Clinical trials A number of clinical trials for auto-immune disease are in progress:DiseaseAntigenMultiple Sclerosis(M

28、S)Myelin Basic Protein(MPB)Rheumatoid Arthritis(RA)Type II collagenType I DiabetesInsulinUveitisS-antigenTransplant RejectionMHC moleculesHuman MS trial 1y double blind study 6/15 MS patients fed MBP had attacks 15/15 control MS patients fed placebo had attacks Those individuals fed myelin had a hig

29、her frequency of TGF producing cells(Fukuara et al.,1996.J Clin Invest 98,70).Human RA trials Several studies have investigated the effect of feeding type II collagen to RA patientsStudy No of centres Dose(mg)Time ResultsGermany 50,1,1012 weeks ndUSA6 0.02-2.512 weeks 1+Investigators are finding tha

30、t dose and frequency are important factorsDiabetes Type I insulin dependent diabetes mellitus(IDDM)Organ specific auto-immune disease T cell mediated destruction of pancreatic beta cells Anti-insulin antibodies develop Susceptibility controlled by environmental&genetic factors(particularly MHC genes

31、)Diabetes Prevention Trial(DPT-1)Multi-centre,randomized,controlled,clinical trial designed to determine if it is possible to prevent or delay the onset of type I diabetes(1994-2002)50%risk injected insulin 25-50%risk oral insulinResults to date Injected insulin failed to prevent or delay the onset

32、of diabetes.Skyler JS et al.,(2002)Effects of insulin in relatives of patients with type 1 diabetes mellitus New England Journal of Medicine 346(22):1685-1691Results to follow The Oral Insulin Trial completed enrollment on October 31,2002.Study investigators are now collecting final data to determin

33、e if oral insulin can delay the onset of type 1 diabetes.They expect to announce trial results in June 2003.Summary of human clinical trials Agents that enhance clinical tolerance are under investigation,eg other cytokines,adjuvants(cholera-toxin).However clinical trials have been disappointing Poor

34、 study design/suboptimal dose/type of antigen/route?http:/ MALT Lamina propria lymphocytes(primarily B cells)(LP major site of Ig synthesis)Lamina propria:the layer of connective tissue underlying the epithelium of a mucous membrane Derived from O-MALT and represent effector and memory cells from ce

35、lls stimulated by antigen Intraepithelial lymphocytes(IELs)Plasma cells producing dimeric IgA Antigen-presenting cells(macrophages and dendritic cells)Modes of Antigen Sampling Stratified,non-keratinized or parakaratinized epithelia(oral cavity,pharynx,esophagus,urethra,vagina)Antigen sampling depen

36、ds on Dendritic cells Langerhans cells,phagocytic,antigen-presenting motile“scouts”)Dendritic cells may then transport antigen to local and regional lymphoid follicles.Simple epithelia(bronchiole,intestine,bronchi)Antigen sampling depends on M cells and Transepithelial transport Dendritic cells may

37、also participate in antigen transportDendritic cells Capture antigen in tissues Transport to secondary lymphoid organs Process and present to T cells An essential link between innate and adaptive immunity May also represent the“Achilles Heel”of the host?(Cutler et al.2001)Maturation of Dendritic Cel

38、ls Loss of endocytic and phagocytic receptors Increased expression of MHC Up-regulation of co-stimulatory molecules(CD80 and CD86)required for T-cell stimulation Up-regulation of CD40 and adhesion molecules ICAM-1 and LFA-3 Fc receptors(endocytosis)decreaseAntigen Sampling across Simple Epithelia Mu

39、cosal surfaces generally lined by a single layer of epithelial cells Barrier sealed by tight junctions that exclude peptides and macromolecules Uptake of antigen requires active transepithelial transport(M-cells or Dendritic cells)Sampling is blocked by mechanisms such as local secretions,sIgA,mucin

40、s,etc.Organization of O-MALTM-CellFollicle-associatedepitheliumDome regionGerminal CenterParafollicularregionLUMENLymphoid FollicleAntigen Adherence to M-Cells Adherence favors endocytosis and transcytosis Adherent materials tend to evoke strong immune responses Wide variety of pathogens adhere to M

41、-cells Mechanism of adherence is unclear Many commensal microorganisms avoid adherence to M-cellsM-Cells May Serve as Entry sites for Pathogenic MicroorganismsBacteria Vibrio cholerae Escherichia coli Salmonella typhi Salmonella typhimurium Shigella flexneri Yersinia enterocolitica Yersinia pseudotu

42、berculosis Campylobacter jejuniViruses Reovirus poliovirus HIVAntigen Recognition Antigen transport is effected by M-Cells which occur over Organized Mucosa-Associated Lymphoid Tissue(O-MALT)After antigen stimulation,effector B-lymphocytes leave O-MALT and migrate to distant mucosal or glandular sit

43、esMigration and Homing of Lymphocytes Distribution of Homing Specificities in Mucosal Tissues Epithelial cells lining postcapillary venules(HEVs)display organ-specific recognition sites called“vascular addressins”Recognized by cell adhesion molecules“homing receptors”High Endothelial Venules(HEV)Con

44、tain specialized endothelial cells lining post capillary venules.Display organ-specific recognition sites called“vascular addressins”that are recognized by specific cell adhesion molecules on lymphocytes.HEV cells are characterized by:Elongated shape and prominent glycocalyx on luminal surface Polar

45、ized,with a domed luminal surface separated from the basolateral surface by adherent junctions,but not tight junctions Cells rest on a basal lamina that constitutes the rate-limiting barrier to migrating lymphocytesHEV(continued)In O-MALT,HEVs are present in T-cell areas between B cell follicles In

46、D-MALT,venules have flat endothelial cells that share many features with HEVs HEVs produce sulfated glycolipids and glycoproteins into the vascular lumen(not known whether these products play a role in homing or extravasation)Adhesion molecules cloned so far belong to four main protein families Inte

47、grins Selectins CAMs(cell adhesion molecules)Proteoglycan-link.core proteinsModulation of Homing Specificities Naive lymphocytes prior to antigenic stimulation demonstrate no migration preference Following antigenic stimulation,lymphocytes acquire homing specificitiesLymphocytes in HEVLymphocytes ad

48、hering to luminal surfaces of HEV endothelial cells.Note microvilli on surface of lymphocytes.Cross-section of HEVTransepithelial Transport in Mucosal ImmunitySamplingSiteEnvironmentEffector SiteDiffuse MALTOrganized MALTMucosal or GlandularTissueTransepithelial Transport of IgA Antibodies Polymeric

49、 immunoglobulin receptor and its intracellular trafficking poly-Ig receptor Binding of IgA to polymeric immunoglobulin receptorTransport and Distribution of IgA AntibodiesEffector Functions of Mucosal Antibodies IgA antibodies are not good mediators of inflammatory reactions complement activation ne

50、utrophil chemotaxis phagocytosis Immune Exclusion/Serve“escort function Beneficial not to induce inflammation Intra-epithelial virus neutralization by IgA Excretory function for IgARelationship between Systemic and Mucosal Immunity Oral tolerance(anergy)Oral administration of antigen suppresses syst

展开阅读全文
相关资源
猜你喜欢
相关搜索

当前位置:首页 > 办公、行业 > 各类PPT课件(模板)
版权提示 | 免责声明

1,本文(5口服免疫和口服疫苗课件.ppt)为本站会员(晟晟文业)主动上传,163文库仅提供信息存储空间,仅对用户上传内容的表现方式做保护处理,对上载内容本身不做任何修改或编辑。
2,用户下载本文档,所消耗的文币(积分)将全额增加到上传者的账号。
3, 若此文所含内容侵犯了您的版权或隐私,请立即通知163文库(发送邮件至3464097650@qq.com或直接QQ联系客服),我们立即给予删除!


侵权处理QQ:3464097650--上传资料QQ:3464097650

【声明】本站为“文档C2C交易模式”,即用户上传的文档直接卖给(下载)用户,本站只是网络空间服务平台,本站所有原创文档下载所得归上传人所有,如您发现上传作品侵犯了您的版权,请立刻联系我们并提供证据,我们将在3个工作日内予以改正。


163文库-Www.163Wenku.Com |网站地图|